Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5600
-0.0050 (-0.88%)
Aug 7, 2026, 4:13 PM AEST
Aroa Biosurgery Financials Overview
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 103.85 | 103.85 | 84.7 | 69.07 | 63.36 | 39.68 |
Revenue Growth | 14.88% | 22.62% | 22.63% | 9.01% | 59.68% | 77.60% |
Gross Profit Gross Profit Growth | 88.83 | 88.83 | 72.61 | 58.97 | 53.48 | 30.3 |
Operating Income Operating Income Growth | 5.68 | 5.68 | -2.92 | -10.67 | -3.11 | -7.64 |
Net Income Net Income Growth | 4.68 | 4.68 | -3.81 | -10.63 | -0.4 | -8.39 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | -0.01 | -0.03 | -0.00 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
United States of America United States of America Growth | 99.17 | 99.17 | 81.19 | 66.29 | 61.63 | 38.6 |
Rest of The World Rest of The World Growth | 4.68 | 4.68 | 3.51 | 2.78 | 1.73 | 1.08 |
Total Total Growth | 103.85 | 103.85 | 84.7 | 69.07 | 63.36 | 39.68 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 27.14 | 27.14 | 22.15 | 30.23 | 45.93 | 57.4 |
Total Debt Total Debt Growth | 6.38 | 6.38 | 6.42 | 7.44 | 7.11 | 5.88 |
Net Cash (Debt) Net Cash Growth | 20.76 | 20.76 | 15.73 | 22.79 | 38.83 | 51.53 |
Net Cash Growth | 24.86% | 31.95% | -30.96% | -41.30% | -24.65% | 148.56% |
Net Cash Per Share Net Cash Per Share Growth | 0.06 | 0.06 | 0.05 | 0.07 | 0.11 | 0.15 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 10.55 | 10.55 | -2.57 | -7.38 | -3.77 | -11.52 |
Capital Expenditures CapEx Growth | -1.11 | -1.11 | -2.31 | -3.52 | -6.03 | -4.46 |
Free Cash Flow Free Cash Flow Growth | 9.44 | 9.44 | -4.88 | -10.9 | -9.8 | -15.98 |
Free Cash Flow Growth | 87.20% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 85.53% | 85.53% | 85.73% | 85.39% | 84.40% | 76.37% |
Operating Margin | 5.47% | 5.47% | -3.45% | -15.45% | -4.91% | -19.26% |
Pretax Margin | 5.08% | 5.08% | -3.84% | -15.10% | -0.61% | -20.82% |
Profit Margin | 4.50% | 4.50% | -4.50% | -15.39% | -0.63% | -21.13% |
FCF Margin | 9.09% | 9.09% | -5.76% | -15.78% | -15.47% | -40.27% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 52.15 | 52.78 | - | - | - | - |
Forward PE | 44.77 | 42.79 | 37.72 | 114.28 | - | - |
P/FCF Ratio | 24.65 | 26.16 | - | - | - | - |
PS Ratio | 2.24 | 2.38 | 1.91 | 3.02 | 6.09 | 7.22 |